Open access
Aug 2026
Chemical probes for Alzheimer's disease targets.
Developing compounds initially developed as potential therapies have provided valuable mechanistic insight, even where they did not translate into clinical benefit, underline the need for rigorous probe selection, validation, and experimental design in AD research.
Sheenagh G. Aiken, Tryfon Zarganes-Tzitzikas, Paul E. Brennan
· Essays in Biochemistry · 0 citations